Clinical Trial on the Effects of Caffeine and Taurine From Energy Drinks (EDs) to Parameters of the Cardiovascular System in Humans

N/ACompletedNCT01421979

University of Hohenheim38 enrolled

Overview

The aim of this study is to examine the safety and the effects of EDs at high doses, either alone or in combination with other risk factors such as alcohol intake, physical exercise and sleep deprivation, on cardiovascular markers and subjective health.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

Conditions

Cardiovascular Risk

Interventions

Energy Drink, Taurine, CaffeineDIETARY_SUPPLEMENT

Eligibility

Sex: ALLMin age: 18 YearsMax age: 25 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * written informed consent * healthy (no acute or chronic desease) * BMI 20,0 - 25,9 kg/m2 * moderate and non-regular consumption of alcohol, EDs and coffee Exclusion Criteria: * pregnancy * regular medication (oral contraceptives permitted) * hypertension and other deseases of the cardiovascular system * liver-deseases * psychiatric deseases * epilepsy * other relevant deseases * (former) alcoholics * non-compliance to the study-protocol * simultaneous participation in another clinical trial * retraction of the written informed consent

Locations (1)

University of Hohenheim

Stuttgart, Baden-Wurttemberg, Germany

Outcomes

Primary Outcomes

Heart-rate-variability (HRV)

Time frame: during 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.